Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Vorinostat and Concomitant Whole Brain Radiation Therapy in Patients With Brain Metastases: A Randomized, Double-blind, Placebo-controlled, Phase II Study

NCT01600742 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT01600742
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01600742 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Vorinostat and Concomitant Whole Brain Radiation Therapy in Patients With Brain Metastases: A Randomized, Double-blind, Placebo-controlled, Phase II Study
Lead sponsor
National Taiwan University Hospital
Phase
Phase 2
Overall status
Terminated
Start date
August 31, 2012
Completion date
December 31, 2013
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain metastasis